Cargando…

Nephrotoxicities

Nephrotoxic medication exposure is nearly ubiquitous in hospitalized patients and represents one of the most common causes of acute kidney injury (AKI) in the hospitalized setting. Although provision of medications that are nephrotoxic has led to improved outcomes in terms of treatment of underlying...

Descripción completa

Detalles Bibliográficos
Autor principal: Goldstein, Stuart L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247779/
https://www.ncbi.nlm.nih.gov/pubmed/28163909
http://dx.doi.org/10.12688/f1000research.10192.1
_version_ 1782497140674658304
author Goldstein, Stuart L.
author_facet Goldstein, Stuart L.
author_sort Goldstein, Stuart L.
collection PubMed
description Nephrotoxic medication exposure is nearly ubiquitous in hospitalized patients and represents one of the most common causes of acute kidney injury (AKI) in the hospitalized setting. Although provision of medications that are nephrotoxic has led to improved outcomes in terms of treatment of underlying illness, unnecessary nephrotoxic medication exposure can be viewed as a potentially modifiable adverse safety event if AKI can be prevented. The advancements in electronic health record development, standardization of AKI definitions, and the ability to identify AKI risk and development in near real time provide opportunities to reduce harm from nephrotoxicity.
format Online
Article
Text
id pubmed-5247779
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-52477792017-02-02 Nephrotoxicities Goldstein, Stuart L. F1000Res Review Nephrotoxic medication exposure is nearly ubiquitous in hospitalized patients and represents one of the most common causes of acute kidney injury (AKI) in the hospitalized setting. Although provision of medications that are nephrotoxic has led to improved outcomes in terms of treatment of underlying illness, unnecessary nephrotoxic medication exposure can be viewed as a potentially modifiable adverse safety event if AKI can be prevented. The advancements in electronic health record development, standardization of AKI definitions, and the ability to identify AKI risk and development in near real time provide opportunities to reduce harm from nephrotoxicity. F1000Research 2017-01-19 /pmc/articles/PMC5247779/ /pubmed/28163909 http://dx.doi.org/10.12688/f1000research.10192.1 Text en Copyright: © 2017 Goldstein SL http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Goldstein, Stuart L.
Nephrotoxicities
title Nephrotoxicities
title_full Nephrotoxicities
title_fullStr Nephrotoxicities
title_full_unstemmed Nephrotoxicities
title_short Nephrotoxicities
title_sort nephrotoxicities
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247779/
https://www.ncbi.nlm.nih.gov/pubmed/28163909
http://dx.doi.org/10.12688/f1000research.10192.1
work_keys_str_mv AT goldsteinstuartl nephrotoxicities